RealWorld4Clinic
Key Info
Basic Information
- Partner:
- Prof. Dr. Nikolaus Marx
- Faculty / Institution:
- Medicine
- Pillar:
- EIT
- Project duration:
- 01.01.2020 to 31.12.2022
- EU contribution:
- 2.998.875 euros
Title
Real-World Cardio-Respiratory Health Monitoring for Clinical Contract Research & Telecardiology
Concept
RealWorld4Clinic will accelerate market launch of a coin-sized medical device anchored to the fundus of the stomach. There it acquires real-life cardio-respiratory health data for exploitation in drug development and tele-cardiology. The clinical trial market will be the stepping stone towards outpatient cardiological care – our priority market. We enrich the device by remote monitoring and data exploitation, training & education, and outcome prediction & performance measurement tools. Co-creation at the hearts of clinical contract research & clinical cardiology ensures patient comfort, workflow compatibility and policy compliance. Our ambition is to make a significant impact on the real-world effectiveness of treatments by pursuing the convergence of clinical research & clinical care. We will improve the predictive power of clinical trials by 50 percent and halve the rate of emergency hospitalisations in heart failure patients – leveraging savings in the amount of billions of euros.
Participants
- Profil GmbH, Germany (Coordinator)
- INSERM – French National Institute of Health and Medical Research, France
- Universitätsklinikum Aachen, Germany
- Université Grenoble Alpes, France
- CHUGA, France
- SentinHealth, France
- Fraunhofer Gesellschaft, Germany
- Grenoble Ecole Management (GEM), France
- MADoPA, France
- Comarch, Poland
This activity has received funding from the European Institute of Innovation and Technology (EIT), a body of the European Union, under the Horizon 2020, the EU Framework Programme for Research and Innovation.